| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2023―Nov―08 |
The prediction of main protease SARS-CoV-2 inhibition based on models of enzyme-inhibitor complexes |
Ya.O. Ivanova, V.S. Skvortsov |
| 2 |
[GO] |
2023―Sep―14 |
Alpha-2 macroglobulin activity in SARS-CoV-2 induced infection and in the post-COVID-19 period |
O.E. Akbasheva, D.K. Mitrofanova, L.V. Spirina, Yu.G. Samoilova, M.V. Matveeva, D.V. Podchinenova, O.A. Oleynik |
| 3 |
[GO] |
2022―Dec―27 |
Molecular basis of biological activity of polysaccharides in COVID-19 associated conditions |
E.A. Generalov, E.Yu. Simonenko, N.G. Kulchenko, L.V. Yakovenko |
| 4 |
[GO] |
2022―Dec―27 |
The prediction of SARS-CoV-2 main protease inhibition with filtering by position of ligand |
Ya.O. Ivanova, A.I. Voronina, V.S. Skvortsov |
| 5 |
[GO] |
2022―Jun―19 |
Proteolysis and deficiency of α1-proteinase inhibitor in SARS-CoV-2 infection |
O.E Akbasheva, L.V. Spirina, D.A. Dyakov, N.V. Masunova |
| 6 |
[GO] |
2021―Jun―17 |
Development of antiviral drugs based on inhibitors of the SARS-COV-2 main protease |
A.V. Sulimov, Kh.S. Shikhaliev, O.V. Pyankov, D.N. Shcherbakov, V.Yu. Chirkova, I.S. Ilin, et al. (+8) D.C. Kutov, A.S. Tashchilova, M.Yu. Krysin, D.V. Krylskiy, N.V. Stolpovskaya, E.A. Volosnikova, S.V. Belenkaya, V.B. Sulimov |
| 7 |
[GO] |
2021―Jun―17 |
Peptide inhibitors of the interaction of the SARS-CoV-2 receptor-binding domain with the ACE2 cell receptor |
R.Sh. Bibilashvili, M.V. Sidorova, U.S. Dudkina, M.E. Palkeeva, A.S. Molokoedov, L.I. Kozlovskaya, et al. (+3) A.M. Egorov, A.A. Ishmukhametov, Ye.V. Parfyonova |
|
